Community-acquired cutaneous ulcer in a child caused by Serratia marcescens

Vineeta Sharma1, Archana Angrup1, Santwana Verma1

  • 1Department of Microbiology, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.

JMM Case Reports
|July 1, 2017
PubMed
Abstract

Insights

Serratia marcescens, a rare cause of community-acquired skin infections, can be challenging to treat due to antibiotic resistance. Prompt diagnosis and susceptibility testing are crucial for effective management of these infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Dermatology

Background:

  • Serratia marcescens is a Gram-negative bacterium commonly associated with hospital-acquired infections.
  • While implicated in various infections, S. marcescens is rarely reported as a cause of community-acquired skin or soft-tissue infections.
  • The organism's ability to produce beta-lactamase poses challenges for antibiotic treatment.

Purpose of the Study:

  • To report a rare case of community-acquired spontaneous cutaneous ulcer caused by Serratia marcescens in an immunocompetent child.
  • To highlight the diagnostic and therapeutic considerations for S. marcescens soft-tissue infections.
  • To emphasize the importance of antimicrobial susceptibility testing for guiding treatment.

Main Methods:

  • Case presentation of a community-acquired cutaneous ulcer in a child.
  • Isolation of Serratia marcescens by culture.
  • Antimicrobial susceptibility testing to determine effective antibiotics.

Main Results:

  • Successful treatment of the cutaneous ulcer with ceftazidime and amikacin based on susceptibility results.
  • Demonstration of Serratia marcescens as the causative agent of the spontaneous ulcer.
  • Improvement in the patient's condition following targeted antibiotic therapy.

Conclusions:

  • Serratia marcescens can cause rare community-acquired soft-tissue infections, even in immunocompetent individuals.
  • Antimicrobial susceptibility testing is essential for effective treatment of Serratia marcescens infections.
  • Combination therapy with ceftazidime and amikacin can be effective for treating S. marcescens infections.